Project: Use of protein-based molecules including monoclonal antibodies aimed at promoting a balanced approach to blood vessel survival in patients with vascular impairments
Innovator: Rocco Rotello, Ph.D.
Description: Current therapies target unique vascular growth factor ligands through trapping or sequestering away from their native receptors, such as Eylea (Regeneron Pharmaceuticals), that binds vascular endothelial growth factor (VEGF) and reduce capillary leak in various eye disorders like age-related macular degeneration. The goal of these kinds of therapy is to reduce leaky vessels and promote stabilization and vessel intactness.
Project: Clinical pharmacist services in ambulatory care setting: Patients' and providers' satisfaction and impact on patient clinical outcomes
Innovator: Juanita Draime, Pharm.D.
Description: The long-term goal of this study is to support the continuing evolution of clinical pharmacist services. This project will assess both provider and patient satisfaction with clinical pharmacist services at a federally-qualified health center as well as assess if there is a correlation between patient satisfaction of clinical pharmacist services and patient clinical outcomes related to services provided (diabetes, hypertension, hyperlipidemia, and anticoagulation). This assessment will provide an evaluation of pharmacist services and allow for improvement and expansion of services to best serve the clinic needs.
Project: Regeneration: Preparing student pharmacists to educate youth on the dangers of prescription drug abuse
Innovators: Aleda Chen, Pharm.D., Ph.D.; Sarah Anderson, Sarah Winey
Description: Given the current opioid crisis and the need for pharmacists to address issues of abuse in the community, student pharmacists were trained using a team-based learning approach to educate youth on prescription drug abuse. Out of this training, student pharmacists then developed curriculum and went to schools and community groups to educate on the dangers of prescription drug abuse.